| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/29/2006 | US20060142171 Novel alkaline protease |
| 06/29/2006 | US20060141627 Vectors for stable gene expression |
| 06/29/2006 | US20060141626 Non-random method of gene shuffling |
| 06/29/2006 | US20060141625 Expression cassette and vector for transient or stable expression of exogenous molecules |
| 06/29/2006 | US20060141624 Method for transferring molecules in vital cells by means of laser beams and arrangement for carrying out said method |
| 06/29/2006 | US20060141602 Packaging of positive-strand RNA virus replicon particles |
| 06/29/2006 | US20060141601 Detergent; polypeptides |
| 06/29/2006 | US20060141594 Simultaneous anaerobic production of isoamyl acetate and succinic acid |
| 06/29/2006 | US20060141590 Dna encoding favin-adenine-dinucleotide-dependent-d-erythronate-4-phosphate-de-hydrogenase, pdxr, and microbial production of vitamin b6 |
| 06/29/2006 | US20060141587 Process for the preparation of L-3, 4-dihydroxyphenylalanine by aerobic fermentation of a microorganism |
| 06/29/2006 | US20060141586 for producing an L-amino acid, for example L-threonine, L-lysine, L-histidine, L-phenylalanine, L-arginine, L-tryptophan or L-glutamic acid; bacterium has been modified to enhance an activity of L-arabinose permease |
| 06/29/2006 | US20060141583 Strain of Streptomyces in which a polyketide synthase gene encoding a polypeptide having the amino acid sequence of SEQ ID NO:14 within an elaiophylin gene cluster is disrupted by the recombinant substitution |
| 06/29/2006 | US20060141580 Encoding protein with immunomodulatory activity, antiviral activity, and antitumor activity; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/29/2006 | US20060141578 effective protein synthesis by regulating the expression of a protein in a host cell; preparing transgenic cells and inducing expression of heterologous sequences; tissue engineering and in vitro translation; efficiency and convenience |
| 06/29/2006 | US20060141573 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 06/29/2006 | US20060141570 Intein-mediated protein purification using in vivo expression of an aggregator protein |
| 06/29/2006 | US20060141567 For selective modulation of leukocyte function, which is useful in a variety of inflammatory and autoimmune diseases, or in therapy of infections |
| 06/29/2006 | US20060141564 Nucleic acids encoding duramycin |
| 06/29/2006 | US20060141563 Mutant protein and refolding method |
| 06/29/2006 | US20060141562 Mutant E. coli appa phytase enzymes and natural variants thereof, nucleic acids encoding such phytase enzymes, vectors and host cells incorporating same and methods of making and using same |
| 06/29/2006 | US20060141561 Apo-2 ligand/trail variants and uses thereof |
| 06/29/2006 | US20060141560 Estrogen receptor genes and utilization thereof |
| 06/29/2006 | US20060141558 Bioproduction of astaxanthin using mutant carotenoid ketolase and carotenoid hydroxylase genes |
| 06/29/2006 | US20060141552 Regulation of human caspase-1-like protease |
| 06/29/2006 | US20060141517 Protein having PDZ domain sequence |
| 06/29/2006 | US20060141515 Polynucleotides encoding plant cysteine proteases |
| 06/29/2006 | US20060141514 Thermus brockianus nucleic acid polymerases |
| 06/29/2006 | US20060141511 Chemical amplification for the synthesis of patterned arrays |
| 06/29/2006 | US20060141510 Method for information processing with nucleic acid molecules |
| 06/29/2006 | US20060141506 Methods for monitoring the expression of alternatively spliced genes |
| 06/29/2006 | US20060141505 Chimeric fusion molecule for analyte detection and quantitation |
| 06/29/2006 | US20060141503 Detection of sequence variation of nucleic acid by shifted termination analysis |
| 06/29/2006 | US20060141501 Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays |
| 06/29/2006 | US20060141499 Methods of determining human egg competency |
| 06/29/2006 | US20060141476 Growth arrest homeobox gene |
| 06/29/2006 | US20060141473 Erk7 and erk8, novel diagnostic markers for cancer |
| 06/29/2006 | US20060141468 Novel notch-like polypeptides |
| 06/29/2006 | US20060141463 Method of detecting bone paget's disease |
| 06/29/2006 | US20060141458 Method of identifying genes involved in cell growth regulation |
| 06/29/2006 | US20060141455 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 06/29/2006 | US20060141454 detection of mesenchymal tumoral cells by using the Slug (zinc fingers domains) gene; biomarker |
| 06/29/2006 | US20060141453 Prokineticin polypeptides, related compositions and methods |
| 06/29/2006 | US20060141452 Method For Synthesizing Single-Stranded Nucleic Acid |
| 06/29/2006 | US20060141451 Guinea pig proteinase-activated receptor 4 and its activating peptide |
| 06/29/2006 | US20060141449 Yeast screens for treatment of human disease |
| 06/29/2006 | US20060141042 Hollow nanoparticle having modified cysteine residue and drug with the use thereof |
| 06/29/2006 | US20060141020 Liposomes containing oligonucleotides |
| 06/29/2006 | US20060140982 Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
| 06/29/2006 | US20060140979 Antigenic polypeptides |
| 06/29/2006 | US20060140978 Constitutive transport enhancer (CTE); Rev Responsive element (RRE); coding sequence for HIV-1 Rev, and a coding sequence for a desired protein that comprises a coding sequence for an HIV structural protein that includes an RRE and at least one CTE; genetic vaccines, gene therapy |
| 06/29/2006 | US20060140975 Regulated bacterial lysis for gene vaccine vector delivery and antigen release |
| 06/29/2006 | US20060140971 Cell surface expression vector of sars virus antigen and microorganisms transformed thereby |
| 06/29/2006 | US20060140969 Hypoallergenic polypeptides based on fish parvalbumin |
| 06/29/2006 | US20060140968 Tumor antigen peptide that is a fragment of a protein and binds to an HLA-A24 antigen and is recognized by cytotoxic T lymphocytes; use in medicaments, prophylactics or diagnostics for tumors that utilize in vivo or in vitro such tumor antigen protein, genes, tumor antigen peptides, or derivatives |
| 06/29/2006 | US20060140965 Immunogenic compositions comprising a xenogenic prostate protein p501s |
| 06/29/2006 | US20060140964 Human igm antibody lysing activated lymphocytes under mediation by homologous complement |
| 06/29/2006 | US20060140954 Novel human protein kinases and protein kinase-like enzymes |
| 06/29/2006 | US20060140945 Nephropathy-associated gene |
| 06/29/2006 | US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/29/2006 | US20060140935 Platlet glycoprotein Ib alpha fusion polypeptides and methods of use thereof |
| 06/29/2006 | US20060140932 Human il-1 beta antagonists |
| 06/29/2006 | US20060140931 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
| 06/29/2006 | US20060140926 Mss4 as an antifungal target |
| 06/29/2006 | US20060140922 Modified by introduction of nucleic acid molecule comprising a nucleic acid sequence encoding granulocyte macrophage-colony stimulating factor (GM-CSF) operably linked to a promoter; contains cancer antigen; immunotherapy |
| 06/29/2006 | US20060140920 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain |
| 06/29/2006 | US20060140910 Recombinant adenoviral vectors and methods of use |
| 06/29/2006 | US20060140909 Method of using adenoviral vectors with increased persistence in vivo |
| 06/29/2006 | US20060140908 Methods for inducing an immune response via oral administration of an adenovirus |
| 06/29/2006 | US20060140905 Chemokine beta-7 variants |
| 06/29/2006 | US20060140875 Semi-soft C-class immunostimulatory oligonucleotides |
| 06/29/2006 | DE10333144B4 Verfahren zur biotechnologischen Herstellung von Citronensäure mit einer genetisch veränderten Hefe Yarrowia lipolytica Process for the biotechnological production of citric acid with a genetically modified yeast Yarrowia lipolytica |
| 06/29/2006 | CA2799802A1 Antibodies directed to angiopoietin-2 and uses thereof |
| 06/29/2006 | CA2594554A1 Plants having increased yield and method for making the same |
| 06/29/2006 | CA2594541A1 Plants having increased yield and method for making the same |
| 06/29/2006 | CA2594228A1 Recombinant dna for expression of proteins for imparting enhanced agronomic traits to transgenic plants |
| 06/29/2006 | CA2594053A1 Vacuole targeting peptide and nucleic acid |
| 06/29/2006 | CA2593956A1 Agents inhibiting the cathelin-like protein cap18/ll-37 |
| 06/29/2006 | CA2593922A1 Recombinant production of serum albumin |
| 06/29/2006 | CA2593920A1 Alpha-amylase variants |
| 06/29/2006 | CA2593872A1 Control sequences responding to amp and uses thereof |
| 06/29/2006 | CA2592495A1 Use of flexible bag containers for viral production |
| 06/29/2006 | CA2592470A1 Method for inducing differentiation to skeletal muscle cells |
| 06/29/2006 | CA2592463A1 Use of atbg1 gene for the generation of transgenic plants with increased resistance to various abiotic stress |
| 06/29/2006 | CA2592390A1 Methods for producing soluble multi-membrane-spanning proteins |
| 06/29/2006 | CA2592249A1 Binding proteins specific for human matriptase |
| 06/29/2006 | CA2592201A1 Neuromedin s and the use thereof |
| 06/29/2006 | CA2592153A1 Resistance genes |
| 06/29/2006 | CA2592138A1 Compositions and methods for expression and purification of fatty acid amide hydrolase |
| 06/29/2006 | CA2592104A1 Enzymes for starch processing |
| 06/29/2006 | CA2592099A1 Conserved hbv and hcv sequences useful for gene silencing |
| 06/29/2006 | CA2592083A1 Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate -binding module as second amino acid sequence |
| 06/29/2006 | CA2592078A1 Detection of human papilloma virus |
| 06/29/2006 | CA2592005A1 Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone |
| 06/29/2006 | CA2591936A1 Plant stress tolerance from modified ap2 transcription factors |
| 06/29/2006 | CA2591813A1 Anti-il-12 antibodies, epitopes, compositions, methods and uses |
| 06/29/2006 | CA2591768A1 Cancer specific antibody and cell surface proteins |
| 06/29/2006 | CA2591665A1 Binding molecules capable of neutralizing west nile virus and uses thereof |
| 06/29/2006 | CA2591510A1 Group b streptococcus |
| 06/29/2006 | CA2591509A1 In-vitro method for producing oocytes or eggs having targeted genomic modification |